阻塞性睡眠呼吸暂停及长期CPAP治疗对黑色素瘤患者预后的作用:443例前瞻性多中心研究
该前瞻性多中心研究纳入443例皮肤黑色素瘤患者,诊断后6个月内行睡眠监测,主要5年结局为复发、转移或死亡的复合终点。中位随访60个月,中重度未治疗OSA与黑色素瘤不良预后独立相关,而CPAP良好依从可避免此超额风险。
要点
- 中重度未治疗OSA是黑色素瘤不良预后的独立危险因素。
- CPAP良好依从与黑色素瘤预后改善相关。
- 黑色素瘤患者应关注OSA筛查与治疗。
核心结论
- 中重度未治疗OSA是黑色素瘤不良预后的独立危险因素。
- CPAP治疗与未治疗的中重度OSA相比,与黑色素瘤预后改善相关。
研究设计与样本
- 前瞻性多中心研究,443例皮肤黑色素瘤患者(2012-2015年诊断)在诊断后6个月内行睡眠监测。
- 主要5年结局为黑色素瘤复发、转移或死亡的复合终点。
- 患者分为四组:AHI<10次/h(无OSA;对照组)、OSA接受CPAP且良好依从、中度OSA(AHI 10-29次/h)未治疗或CPAP依从差、重度OSA(AHI≥30次/h)未治疗或CPAP依从差。
- 中位随访60个月(四分位距51-74个月)。
主要发现
- 随访期间发生32例复发、53例转移、52例死亡(116例患者至少发生一项主要复合结局)。
- 调整年龄、性别、诊断时前哨淋巴结受累、BMI、糖尿病、夜间血氧饱和度低于90%的时间、Breslow指数、Epworth嗜睡量表评分和黑色素瘤治疗后,中度OSA(HR 2.45;95%CI 1.09-5.49)和重度OSA(HR 2.96;95%CI 1.36-6.42)与对照组相比与黑色素瘤预后较差相关。
- CPAP良好依从可避免此超额风险(HR 1.66;95%CI 0.71-3.90)。
临床怎么用
- 对黑色素瘤患者应关注OSA的筛查,尤其存在中重度OSA时。
- 对合并中重度OSA的黑色素瘤患者,应评估并鼓励CPAP治疗及良好依从。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: OSA has been associated with increased incidence and aggressiveness of melanoma. However, the long-term impact of OSA and CPAP treatment on the prognosis of melanoma remains unexplored. RESEARCH QUESTION: Are OSA and CPAP treatment associated independently with a poor prognosis for cutaneous melanoma? STUDY DESIGN AND METHODS: Four hundred forty-three patients with a diagnosis of cutaneous melanoma (2012-2015) underwent a sleep study within 6 months of diagnosis. The main 5-year outcome of the study was a composite of melanoma recurrence, metastasis, or mortality. Patients were divided into four groups: baseline apnea-hypopnea index (AHI) of fewer than 10 events/h (no OSA; control group), OSA treated with CPAP and good adherence, untreated or poor CPAP adherence in moderate (AHI, 10-29 events/h), and severe OSA (AHI, ≥ 30 events/h). Survival analysis was used to determine the independent role of OSA and CPAP treatment on melanoma composite outcome. RESULTS: Three hundred ninety-one patients (88.2%) were available for analysis at 5-year follow-up (mean age, 65.1 ± 15.2 years; 49% male; Breslow index, 1.7 ± 2.5 mm). One hundred thirty-nine patients had AHI of fewer than 10 events/h (control group); 78 patients with OSA were adherent to CPAP; and 124 and 50 patients had moderate and severe OSA, respectively, without CPAP treatment. Median follow-up was 60 months (interquartile range, 51-74 months). During follow-up, 32 relapses, 53 metastases, and 52 deaths occurred (116 patients showed at least one of the main composite outcomes). After adjusting for age, sex, sentinel lymph nodes affected at diagnosis, BMI, diabetes, nighttime with an oxygen saturation below 90%, Breslow index, Epworth sleepiness scale scores, and melanoma treatment, moderate (hazard ratio [HR], 2.45; 95% CI, 1.09-5.49) and severe OSA (HR, 2.96; 95% CI, 1.36-6.42) were associated with poorer prognosis of melanoma compared with the control group. However, good adherence to CPAP avoided this excess risk (HR, 1.66; 95% CI, 0.71-3.90). INTERPRETATION: Moderate to severe untreated OSA is an independent risk factor for poor prognosis of melanoma. Treatment with CPAP is associated with improved melanoma outcomes compared with untreated moderate to severe OSA.
引用
- Gómez-Olivas JD, Campos-Rodriguez F, Nagore E, et al. Role of Sleep Apnea and Long-Term CPAP Treatment in the Prognosis of Patients With Melanoma: A Prospective Multicenter Study of 443 Patients. Chest. 2023. PMID: 37348828. doi:10.1016/j.chest.2023.06.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。